Your browser doesn't support javascript.
loading
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors.
Kitano, Shigehisa; Fujiwara, Yutaka; Shimizu, Toshio; Iwasa, Satoru; Yonemori, Kan; Kondo, Shunsuke; Shimomura, Akihiko; Koyama, Takafumi; Ebata, Takahiro; Ikezawa, Hiroki; Hayata, Nozomi; Minoshima, Yukinori; Miura, Takuma; Kubota, Tomoki; Yamamoto, Noboru.
Affiliation
  • Kitano S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan. shigehisa.kitano@jfcr.or.jp.
  • Fujiwara Y; Department of Advanced Medical Development, The Cancer Institute Hospital of JFCR, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan. shigehisa.kitano@jfcr.or.jp.
  • Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Iwasa S; Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Japan.
  • Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Shimomura A; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Ebata T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Ikezawa H; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hayata N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Minoshima Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Miura T; Clinical Data Science Department, Eisai Co., Ltd, Tokyo, Japan.
  • Kubota T; Clinical Pharmacology Science Department, Eisai Co., Ltd, Tokyo, Japan.
  • Yamamoto N; Tsukuba Research Laboratories, Eisai Co., Ltd, Ibaraki, Japan.
Cancer Chemother Pharmacol ; 90(6): 523-529, 2022 12.
Article in En | MEDLINE | ID: mdl-36289094
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Carcinoma, Non-Small-Cell Lung / Kidney Neoplasms / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Cancer Chemother Pharmacol Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Carcinoma, Non-Small-Cell Lung / Kidney Neoplasms / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Cancer Chemother Pharmacol Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Alemania